Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Manijeh Goldberg
Observed name:
Manijeh Nazari Goldberg
Institution:
Privo Technologies (United States)
Observed institutions:
University of Massachusetts Lowell,
Harvard–MIT Division of Health Sciences and Technology,
Privo Technologies (United States),
Koch Institute for Integrative Cancer Research At MIT,
Massachusetts Institute of Technology
ORCID:
0000-0002-6134-8161
Observed ORCID:
0000-0002-6134-8161
OpenAlex ID:
A5000536355
Works
8
Awards
9
A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer
2022
·
Manijeh Goldberg
, Aaron Manzi
, et al.
·
Nature Communications
·
83
PDF
Development of a Nanoparticle-Embedded Chitosan Sponge for Topical and Local Administration of Chemotherapeutic Agents
2014
·
Manijeh Goldberg
, Aaron Manzi
, et al.
·
Journal of Nanotechnology in Engineering and Medicine
·
17
PDF
Author Correction: A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer
2022
·
Manijeh Goldberg
, Aaron Manzi
, et al.
·
Nature Communications
·
6
PDF
A phase II study of PRV111 nanoengineered cisplatin patch as a neoadjuvant therapy for early-stage oral squamous cell carcinoma (OSCC).
2021
·
Nishant Agrawal
, Evgeny Izumchenko
, et al.
·
Journal of Clinical Oncology
·
6
Abstract LB024: Permeation enhancer is necessary for the optimized PRV131 mediated cisplatin intratumoral delivery
2024
·
Manijeh Goldberg
, Aaron Manzi
, et al.
·
Cancer Research
Abstract LB440: PRV131 is an effective and safe polymeric nanoparticle suspension for intratumoral cisplatin delivery
2024
·
Manijeh Goldberg
, Aaron Manzi
, et al.
·
Cancer Research
Best antibiotics for buccal delivery
2011
·
Manijeh Goldberg
·
DSpace@MIT (Massachusetts Institute of Technology)
Show more works
View as search
Works count:
8
Citation count:
112
H-index:
4
I10-index:
2
Year
Topic
Type